HALO
HALOZYME THERAPEUTICS, INC. · Search Wikipedia for HALOZYME THERAPEUTICS, INC. · Yahoo Finance chart ↗
Price
- Last close
- $108.44Last update Sep 16, 2026
- 12-month high
- $111.15
- 12-month low
- $61.23
Reported holders
Reported purchases with no subsequent reported sale.
| Name | Purchased | Price that day | ROI |
|---|---|---|---|
| Gilbert Cisneros Rank #49 | Mar 9, 2026 | $68.14 | +59.14% |
Prices are the market close on the purchase date; exact purchase prices are not disclosed. ROI is the percentage gain or loss from that price to the last close.
All trades
| Ticker | Politician Name | Transaction Type | Trade Date | Found Date |
|---|---|---|---|---|
| HALO — Halozyme Therapeutics, Inc. - Common Stock (HALO) [ST], Gilbert Cisneros, purchase, Mar 9, 2026 | Gilbert Cisneros Rank #49 | Purchase | Mar 9, 2026 | Sep 11, 2026 |
| HALO — Halozyme Therapeutics, Inc. - Common Stock (HALO) [ST], Gilbert Cisneros, sale, Mar 24, 2025 | Gilbert Cisneros Rank #49 | Sale | Mar 24, 2025 | Sep 11, 2026 |
| HALO — Halozyme Therapeutics, Inc. - Common Stock (HALO) [ST], Josh Gottheimer, sale, Sep 9, 2024 | Josh Gottheimer Rank #56 | Sale | Sep 9, 2024 | Sep 11, 2026 |
| HALO — Halozyme Therapeutics, Inc. (HALO) [ST], Daniel Goldman, sale, Jul 12, 2023 | Daniel Goldman Rank #74 | Sale | Jul 12, 2023 | Sep 12, 2026 |
| HALO — Halozyme Therapeutics, Inc. (HALO) [ST], Josh Gottheimer, sale, Dec 6, 2022 | Josh Gottheimer Rank #56 | Sale | Dec 6, 2022 | Sep 12, 2026 |